"I think that overall, one should do what one is comfortable with, within the scope of your practice and your resources," says Smita De, MD, PhD.
In this video, Smita De, MD, PhD, shares the take-home message from the recent Urology study “Is it Safe to Continue Aspirin in Patients Undergoing Percutaneous Nephrolithotomy?” De is a staff physician at the Glickman Urological & Kidney Institute at Cleveland Clinic, Cleveland, Ohio and a clinical assistant professor of urology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
I think that overall, one should do what one is comfortable with, within the scope of your practice and your resources. If a patient does require a PCNL, and that is something that you are comfortable doing, and that patient does need to stay on their aspirin, especially low-dose aspirin—which was the majority of the cohort in our study—there doesn't appear to be an increased risk of bleeding complications. Again, I want to point out [that] this is not a randomized trial, which, of course, would provide the highest level of evidence for that.
Over the past few years, since we started this study, there's been a rapid increase in the use of mini PCNL and all the other miniaturization type of techniques and instrumentation. I would suspect that now there's an even more decreased risk of bleeding overall, and certainly then in these patients who require continuation of their aspirin, I think we can be even more comfortable with proceeding on those patients.
This transcription was edited for clarity.
Bundled payment program covers kidney stone care
July 22nd 2024"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
FDA grants 510(k) clearance to Ambu’s single-use ureteroscope
July 2nd 2024"This clearance in the US of our new ureteroscopy solution not only demonstrates a market expansion for Ambu; it is a testament to the progressive shift towards single-use solutions within the field of urology," says Britt Meelby Jensen.
Data support shock wave lithotripsy for pediatric patients with kidney stones
May 28th 2024Regarding patient-reported outcomes, those who underwent URS showed higher urinary symptoms, greater pain intensity, and greater pain interference at 1 week following surgery compared with those who underwent SWL.